Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
Beyond LDL: Exploring the Evolving Role of Fibrate Drugs in Lipid Management
According to a new report by Polaris Market Research, the global Fibrate Drugs market was valued at USD 1.5 billion in 2024 and is projected to reach USD 1.8 billion by 2034, expanding at a CAGR of 2.12% over the forecast period. Growth is underpinned by rising hyperlipidemia cases, expanding combination therapies for cardiovascular risk management, and accelerating research into...
0 Comments ·0 Shares ·102 Views ·0 Reviews
Please log in to like, share and comment!